SCM
HZNP

Silverarc Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-23,054
Closed -$2.62M 100
2022
Q4
$2.62M Buy
23,054
+12,923
+128% +$1.47M 0.75% 41
2022
Q3
$627K Sell
10,131
-62,056
-86% -$3.84M 0.21% 57
2022
Q2
$5.76M Buy
72,187
+4,745
+7% +$378K 1.77% 14
2022
Q1
$7.1K Buy
67,442
+5,742
+9% +$604 2.94% 8
2021
Q4
$6.65M Buy
61,700
+9,231
+18% +$995K 2.69% 11
2021
Q3
$5.75M Buy
52,469
+2,434
+5% +$267K 3.25% 6
2021
Q2
$4.69K Buy
50,035
+1,559
+3% +$146 2.09% 13
2021
Q1
$4.46M Buy
48,476
+18,476
+62% +$1.7M 2.43% 10
2020
Q4
$2.2M Buy
+30,000
New +$2.2M 1.28% 30